MYCOF - Mydecine Innovations Group GAAP EPS of -C$0.35 August, 16 2022 05:48 AM New Age Brands Mydecine Innovations Group press release ( OTCPK:MYCOF ): Q2 GAAP EPS of -C$0.35. The Company had C$324,146 in cash and cash equivalents as of June 30, 2022. For further details see: Mydecine Innovations Group GAAP EPS of -C$0.35